VIRIDIAN THERAPEUTICS INC

17 sept. 2026, 19:46 UTC

Viridian Therapeutics Inc shares fell sharply as the company navigates post-FDA approval dynamics for Lumvoa, remaining below its 20-day moving average.

16 sept. 2026, 22:01 UTC

Viridian Therapeutics Inc is rising in after-market trading, moving from a low of 1.02% to a high of 1.20% since Wednesday's close.

15 sept. 2026, 19:36 UTC

Viridian Therapeutics shares are lower today, continuing a decline since Monday amid broader market pressure from rising treasury yields. No specific news was identified.

14 sept. 2026, 20:13 UTC

Viridian Therapeutics Inc. shares are higher in after-market hours, maintaining a cumulative return since Monday's close, despite a weaker performance backdrop.

11 sept. 2026, 23:26 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Recent U.S. inflation data adds broader context.

10 sept. 2026, 20:13 UTC

Viridian Therapeutics Inc. shares are higher in after-market trading, though they remain below the 20-day moving average and near the lower end of their one-month range.

9 sept. 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, declining from an initial drop to a more pronounced decrease amid weak trading.

8 sept. 2026, 20:13 UTC

Viridian Therapeutics Inc shares are higher in after-market trading. No specific news was identified to explain the price movement.

3 sept. 2026, 19:16 UTC

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026. Shares are slightly higher during Thursday's session.

2 sept. 2026, 22:06 UTC

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026, with a fireside chat accessible via a live webcast. Shares are little changed.

28 aug. 2026, 20:02 UTC

Viridian Therapeutics Inc shares are lower today, breaking a trend of higher closes. Broader market pressures from rising U.S. Treasury yields may be influencing this decline.

27 aug. 2026, 22:01 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, reflecting notable weakness following a flat start to the session. No specific news was identified.

25 aug. 2026, 20:07 UTC

Viridian Therapeutics is gaining amid a broader positive market trend, despite earlier pulling back from a session high. Shares remain above the 20-day moving average.

24 aug. 2026, 19:26 UTC

Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.

21 aug. 2026, 23:21 UTC

Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.

20 aug. 2026, 22:56 UTC

Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.

19 aug. 2026, 23:01 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.

17 aug. 2026, 20:06 UTC

Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.

14 aug. 2026, 19:56 UTC

Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.

13 aug. 2026, 19:56 UTC

Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.

11 aug. 2026, 19:46 UTC

Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.

7 aug. 2026, 20:05 UTC

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6 aug. 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5 aug. 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4 aug. 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

3 aug. 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

31 iul. 2026, 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

30 iul. 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

29 iul. 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

28 iul. 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.